Protzel C, Kakies C, Kleist B, Poetsch M, Giebel J
Department of Urology, Ernst Moritz Arndt University, Fleischmannstr. 42-44, 17475, Greifswald, Germany.
Virchows Arch. 2008 Apr;452(4):369-75. doi: 10.1007/s00428-008-0590-0. Epub 2008 Feb 28.
In penile squamous cell carcinoma (PSCC), the outcome largely depends on early detection and resection of inguinal lymph node metastases. We investigated the role of metastasis suppressor protein kang ai 1 (KAI1)/cluster of differentiation 82 (CD82), which is known to be of prognostic significance for a wide variety of cancers. Moreover, we analysed the tumours for human papillomavirus (HPV) DNA and loss of heterozygosity at the 11p11.2 locus. Tissue samples of 30 primary PSCCs were investigated immunohistochemically using an anti-KAI1/CD82 polyclonal antibody. The expression was assessed according to the degree of KAI1/CD82-positive tumour cells as positive, decreased or negative. The presence of HPV6/11, HPV16 and HPV18 DNA was analysed by polymerase chain reaction. All patients with decreased or negative expression of KAI1/CD82 in primary lesions had lymph node metastases (p = 0.0002). Patients with positive KAI1/CD82 expression showed a significant better prognosis for survival compared to the other groups (p = 0.0042). Presence of HPV DNA was associated with decreased or negative KAI1/CD82 expression. Lacking or decreased expression of metastasis suppressor gene KAI1/CD82 appears to be a prognostic parameter for the occurrence of lymph node metastases in PSCC. Our study suggests an association of decreased KAI1/CD82 expression with tumour progression, development of metastases and disease-specific death.
在阴茎鳞状细胞癌(PSCC)中,治疗结果很大程度上取决于腹股沟淋巴结转移的早期检测和切除。我们研究了转移抑制蛋白抗癌1(KAI1)/分化簇82(CD82)的作用,已知其对多种癌症具有预后意义。此外,我们分析了肿瘤中的人乳头瘤病毒(HPV)DNA以及11p11.2位点的杂合性缺失。使用抗KAI1/CD82多克隆抗体对30例原发性PSCC的组织样本进行免疫组织化学研究。根据KAI1/CD82阳性肿瘤细胞的程度将表达评估为阳性、降低或阴性。通过聚合酶链反应分析HPV6/11、HPV16和HPV18 DNA的存在情况。所有原发性病变中KAI1/CD82表达降低或阴性的患者均有淋巴结转移(p = 0.0002)。与其他组相比,KAI1/CD82表达阳性的患者生存预后明显更好(p = 0.0042)。HPV DNA的存在与KAI1/CD82表达降低或阴性相关。转移抑制基因KAI1/CD82表达缺失或降低似乎是PSCC发生淋巴结转移的一个预后参数。我们的研究表明KAI1/CD82表达降低与肿瘤进展、转移发生和疾病特异性死亡之间存在关联。
Int J Clin Exp Pathol. 2013-5-15
Eur Rev Med Pharmacol Sci. 2018-9
Ann Afr Med. 2024-10-1
Front Oncol. 2021-9-3
Int J Mol Sci. 2021-5-9
Urologe A. 2019-7
Onco Targets Ther. 2017-12-6
Mol Carcinog. 2014-8
Nat Med. 2006-8
Trends Mol Med. 2005-12
Hepatogastroenterology. 2005